Ambassadeur de la Health Valley, Debiopharm dirige le A-Round du finlandais Kaiku Health

Ambassadeur de la Health Valley, Debiopharm dirige le A-Round du finlandais Kaiku Health

Finnish digital health company Kaiku Health Oy, which provides intelligent patient monitoring software for healthcare providers across Europe, has closed a €4.4 million funding round. The investment was led by Debiopharm Innovation Fund SA and Tesi with participation from Prodeko Ventures Oy and existing investors Reaktor Ventures Oy, Metsola Ventures Oy, and Athensmed Oy. Kaiku Health will use the funding to power its international expansion and further develop its digital therapeutics pipeline.

MORE

Leave a reply